Home6541 • TPE
add
Tanvex Biopharma Inc
Previous close
$47.50
Day range
$47.20 - $48.30
Year range
$44.00 - $88.95
Market cap
7.87B TWD
Avg Volume
381.38K
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 9.09M | 14.95% |
Operating expense | 496.64M | 7.56% |
Net income | -518.02M | -8.37% |
Net profit margin | -5.70K | 5.73% |
Earnings per share | — | — |
EBITDA | -463.24M | -7.25% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 380.75M | -51.57% |
Total assets | 2.76B | -19.19% |
Total liabilities | 1.94B | -4.24% |
Total equity | 821.11M | — |
Shares outstanding | 133.96M | — |
Price to book | 7.75 | — |
Return on assets | -39.68% | — |
Return on capital | -42.66% | — |
Cash Flow
Net change in cash
(TWD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -518.02M | -8.37% |
Cash from operations | -416.38M | -41.98% |
Cash from investing | -20.24M | 42.50% |
Cash from financing | -35.55M | -39.15% |
Net change in cash | -493.03M | -28.11% |
Free cash flow | -235.62M | -49.72% |
About
Founded
2013
Website
Employees
197